GeniPhys Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $6M

  • Investors
  • 4

GeniPhys General Information

Description

Developer of novel polymerizable collagen product designed to support site-appropriate tissue generation without evoking inflammation. The company's technology offers polymerizable collagen that supports the custom design and fabrication of collagen materials for improvising tissue restoration and regeneration, enabling medical researchers to offer potential material applications that extend from regenerative tissue replacements to the delivery of pharmaceutical and cell-based therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 7750 Zionsville Road
  • Suite 200
  • Indianapolis, IN 46268
  • United States
+1 (317) 000-0000

GeniPhys Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GeniPhys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 14-Mar-2023 $6M 00.00 0000 Completed Pre-Clinical Trials
6. Grant 28-Feb-2022 00000 00000 Completed Pre-Clinical Trials
5. Grant 01-Jul-2019 00000 00000 Completed Pre-Clinical Trials
4. Early Stage VC 10-Jan-2017 0000 00000 Completed Pre-Clinical Trials
3. Early Stage VC 19-May-2015 0000 00000 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) $100K $100K Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view GeniPhys’s complete valuation and funding history, request access »

GeniPhys Patents

GeniPhys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230131204-A1 High-strength collagen compositions and methods of use Pending 31-Mar-2020 000000000
CA-3175543-A1 High-strength collagen compositions and methods of use Pending 31-Mar-2020 000000000
EP-4125777-A1 High-strength collagen compositions and methods of use Pending 31-Mar-2020 000000000
US-20220257836-A1 Biologic filler for restoring and regenerating tissue Pending 27-Jan-2020 000000000
EP-4096635-A1 Biologic filler for restoring and regenerating tissue Pending 27-Jan-2020 A61L27/502
To view GeniPhys’s complete patent history, request access »

GeniPhys Executive Team (3)

Name Title Board Seat Contact Info
Andrew Eibling Chief Executive Officer, President and Board Member
Sherry Harbin Ph.D Founder, Chief Scientific Officer, Chief Technology Officer & Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

GeniPhys Board Members (3)

Name Representing Role Since
John DeFord Self Board Member 000 0000
R. Matthew Neff JD Self Chairman 000 0000
Shaun Hawkins Pier 70 Ventures Board Member 000 0000
To view GeniPhys’s complete board members history, request access »

GeniPhys Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GeniPhys Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Pier 70 Ventures Venture Capital Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
Elevate Ventures Venture Capital Minority 000 0000 000000 0
Purdue Research Foundation Limited Partner 000 0000 000000 0
To view GeniPhys’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »